Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Abcam Announces Winner of 15 Discoveries Contest

Published: Tuesday, February 04, 2014
Last Updated: Monday, February 03, 2014
Bookmark and Share
Contest celebrates scientific breakthroughs with $15,000 research grant.

Abcam plc has announced Yali Huang as the winner of its 15 discoveries contest. Ms. Huang conducts her work at the Early Embryo Development lab at the MRC Centre of Regenerative Medicine, University of Edinburgh, Scotland.

The contest recognizes the most innovative and exciting scientific breakthroughs of the last 18 months supported by Abcam products.

In recognition of her winning entry, Ms. Huang’s lab will receive a $15,000 lab research grant and $1,000 worth of Abcam products. Her project, titled ‘In Vivo Differentiation Potential of Epiblast Stem Cells Revealed by Chimeric Embryo Formation’, was selected from over 80 global submissions by an expert panel of scientists (www.abcam15.com/judges).

Illustrating the importance of the host environment on Chimera formation, the research contributes to a greater understanding of how cultured stem cells relate to the early embryo.

Ms. Huang said: “We’re delighted to have won the 15 discoveries contest and would like to thank Abcam for their support in making our research project a success. At a time when budgets are under pressure the grant will be extremely beneficial to our lab, to help us further our discoveries.”

Dr Jonathan Milner, CEO, Abcam, said: “The 15 discoveries contest is Abcam’s way of recognizing the hard work and achievements of life science researchers. We are fortunate to live in a time where, thanks to great advances in biology tools and techniques, researchers are able to make almost daily breakthroughs in our understanding of how cells operate in health and disease. Abcam’s goal is to continue supporting these breakthroughs, enabling scientists to discover more.”

Abcam is committed to supporting scientists with their life science discoveries and continually looks at new ways to innovate its products and services. This includes development of pioneering research tools such as its proprietary rabbit monoclonal antibody technology, RabMAb®.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Stem Cells Rescue Patients from Mitochondrial Disease
A study led by OHSU researchers has revealed a critical first step in developing a new gene and stem cell regenerative technique for treating patients with mitochondrial disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!